Daily Judi: Monday, November 14, 2022
Every day we scan the headlines for the best items that engage the clinical trial ecosystem, workflow solutions, and more—all the latest news you need to know. Here are today's stories:
Kyle Barr at Gizmodo looks at the recent chaos on Twitter, and how much tweets by a copycat Eli Lilly account may have cost the pharmaceutical giant.
Roche’s Alzheimer’s drug, gantenerumab, didn't appear to slow the degenerative disease in two large Phase 3 clinical trials. (BioPharma Dive)
Shania Kennedy examines how artificial intelligence may better the patient experience in future decentralized clinical trials. (Health IT Analytics)
The CNS Summit 2022 will be held on November 17–20, in Boca Raton, Florida. Created as "a community of innovators and industry leaders who are not afraid to challenge the status quo," CNS was founded in 2009 to advance clinical development, focused on collaboration and innovation. Team AG Mednet will be there!
Our Culture
“I work mainly with one CRO, and they thank us for being proactive, and for our precise attention. We get a lot of appreciation from their whole team as we help them with their deliverable.”
–Jess, Program Manager
About Judi
Judi speeds and improves the world's clinical trial workflows. Our cloud-based platform has 120,000 users across 168 countries. We eliminate the chaos so clinical teams can focus on the patient, rather than the process. We are a SOC 2 Type II certified collaboration platform.